Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: Evaluation in the target population of screening and comparison with qualitative tests

American Journal of Gastroenterology

Volumn 105, Issue 3, 2010, Pages 682-690

  Haug, Ulrike ^a   Hundt, Sabrina ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COLON ADENOMA; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RECTUM ADENOMA; SCREENING TEST;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOASSAY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 77949266481     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.668     Document Type: Article

References (22)

1. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008:a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-1595 (Pubitemid 351615355)
2. Burch JA, Soares-Weiser K, St John DJ, et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer:a systematic review. J Med Screen 2007;14:132-137
3. Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer:a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:638-658
4. Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009;150:162-169
5. http://www.r-biopharm.com/product-site.php?product-id=39&, accessed 10 April 2009.
6. Deeks JJ, Altman DG. Diagnostic tests 4:likelihood ratios. BMJ 2004;329:168-169
7. Altman DG, Machin D, Bryant TN, Gardner MJ. Statistics With Confidence, 2nd edn, BMJ Books, London, 2000.
8. http://www.medcalc.be/, accessed 20 April 2009.
9. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves:a nonparametric approach. Biometrics 1988;44:837-845
10. Sieg A, Thoms C, L ü thgens K, et al. Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces. Int J Colorectal Dis 1999;14:267-271
11. Tannous B, Lee-Lewandrowski E, Sharples C, et al. Comparison of conventional guaiac to four immunochemical methods for fecal occult blood testing:implications for clinical practice in hospital and outpatient settings. Clin Chim Acta 2009;400:120-122
12. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-428
13. Morikawa T, Kato J, Yamaji Y, et al. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol 2007;102:2259-2264
14. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
15. Cole SR, Young GP, Esterman A, et al. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-122
16. van Rossum LG, van Rijn AF, van Oijen MG, et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer 2009;125:746-750
17. http://www.zi-berlin.de/koloskopie/downloads/Jahresbericht-2006-Berlin- Vers-1-1.pdf, accessed 2 September 2009.
18. Barclay RL, Vicari JJ, Doughty AS, et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006;355:2533-2541
19. Hixson LJ, Fennerty MB, Sampliner RE, et al. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst 1990;82:1769-1772
20. Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997;112:24-28
21. Haug U, Brenner H. New stool tests for colorectal cancer screening:a systematic review focusing on performance characteristics and practicalness. Int J Cancer 2005;117:169-176
22. Hundt S, Haug U, Brenner H. Blood markers for early detection of colorectal cancer:a systematic review. Cancer Epidemiol Biomarkers Prev 2007;16:1935-1953